Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 micro g in the treatment of seasonal allergic rhinitis Kaliner MA et al. - No significant between-treatment differences were determined for the average 2-week percent changes from baseline for congestion, runny nose, sneezing, itchy nose, and ocular symptoms, although olopatadine had a faster onset of action for reducing all symptoms. Both treatments were safe and well tolerated. Olopatadine and fluticasone nasal sprays both reduced nasal and ocular SAR symptoms with no significant between-treatment differences except for a faster and greater onset of action with olopatadine. [more...]
